IM

HEPATITIS A

Key Features

  1. Most common cause of acute viral hepatitis.
  2. Causes only acute hepatitis. No carrier state or chronic hepatitis. Usually, does not happen twice.

Transmission

  • Fecal-oral route: Contamination of food and water due to poor hygiene by food handlers.
  • Saliva of the infected person also contains the virus but in very small amounts.

Clinical Features

Prodromal Phase (Initial 1-2 weeks)

  • Anorexia (loss of appetite)
  • Nausea
  • Malaise (general feeling of discomfort)
  • Bad taste in the mouth
  • Fever
  • Jaundice is absent initially

Icteric Phase (Next 3-6 weeks)

  • Jaundice (yellowing of skin and eyes)
  • Pain in the right upper quadrant of the abdomen
  • Dark urine
  • Pale stools
  • Tender hepatomegaly (enlarged liver)

Severity of Hepatitis A

  • Asymptomatic: Usually in children
  • Mild to Moderate Symptoms: Most cases
  • Fulminant Hepatic Failure: Rare but serious complication

Investigations

  • Liver Function Tests (LFTs):
    • High bilirubin (mainly direct bilirubin)
    • AST & ALT are very high
    • Alkaline Phosphatase slightly high
  • Urine: Contains bilirubin
  • Diagnostic Test: Hepatitis A antibody (anti-HAV)

Treatment

  • No specific drug treatment. The disease is self-limited and usually results in complete recovery within 3 months.
  • Strict isolation of the patient is not advised, but they should wash their hands thoroughly after defecation.
  • Good nutrition: Eat whatever can be tolerated.
  • Vitamin supplements
  • Avoid alcohol and hepatotoxic drugs
  • Symptomatic treatment

Prevention

  • General Measures:
    • Good hygiene
    • Drink bottled water in high-risk areas
    • Avoid risky foods
  • Immunization: Hepatitis A vaccine is recommended for:
    • Patients with other chronic liver disease
    • Patients traveling to a high-risk area for a long time

Rapid Fire Questions (Hepatitis A)

  • Mode of transmission of Hep A? fecal oral
  • Which test is diagnostic? anti-HAV
  • In hepatitis, which type of bilirubin is elevated predominantly? Direct
  • Which specific drug is used for Hep A treatment? no specific drug
  • Who should get the Hep A vaccine? High risk area for CHD
  • How to avoid getting infected? avoid risk factors
  • A man tells you that he had Hep A 2 years ago. Now he is jaundiced. The doctor tells him that he has Hep A re-infection. Is the doctor right? no, antibodies protective for life


Thera

Transmission:

  • Fecal-oral: contaminated water or food (raw shellfish).
  • Anal oral sex.
  • Parenteral (not common).

Pathogenesis:

  • hepatocytes destruction by the immune system,
  • (the virus is not cytopathic).

Clinical features:

  • Right upper quadrant pain, tender hepatomegaly, fever, malaise, anorexia, nausea, vomiting, jaundice (dark urine and pale stools), pruritus.
  • Mortality rate is 0.1–0.3%.

Diagnoses:

  • Antigens detection in stool.
  • RNA detection in stool & blood samples by rt-PCR.
  • Anti-HAV IgM in serum.
  • IgM - Currently infected
  • IgG - infected before

Treatment

  • Generally self-limited.
  • Symptomatic treatment: antiemetics, rehydration.
  • Use medications that are metabolized by the liver with caution (e.g., acetaminophen “paracetamol”).

Prevention:

  • Inactivated vaccine.